MKMurat Kosan

Murat Kosan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Murat Kosan has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Changes in β3 receptor levels in diabetes mellitus and infravesical obstruction-induced cystopathy in rat bladders

    by Seyhan Tezcan, Murat Kosan, Aysel Güven Bağla, Eyüp Burak Sancak, Sait Elmas

    Aim This study aims to immunohistochemically determine potential changes in the number of β3 receptors caused by diabetes and bladder outlet obstruction (BOO), an ailment whose frequency increases with age. Methods Four distinct groups, each comprising 12 rats, were established: a control group, a diabetic group, an obstructive group, and a diabetic obstructive group. To induce moderate obstruction, a 5 Fr catheter was utilized. For moderate diabetes induction, a dose of 50 mg/kg STZ was intraperitoneally administered to the rats. Over 8 weeks, the rats’ blood sugar and body weight levels were closely monitored. After euthanasia, the rats’ bladder tissues were extracted for subsequent histological and immunohistochemical assessments. Statistical analyses were conducted to compare the results, with significance attributed to p-values < 0.05. Results The histopathological examination revealed notable variances among the groups concerning urothelial hyperplasia and inflammation. Moreover, a discernible increase in intensity of β3 receptor staining was noted in the obstructive group when compared to the control group, whereas a decrease was observed in both the diabetic and diabetic obstructive groups. Conclusion Alterations in receptor count may not necessarily correspond to equivalent changes in receptor functionality. Consequently, a comprehensive evaluation of receptor function necessitates diverse in vivo and in vitro investigations.

  • Open Access

    Predictive values of vascular endothelial growth factor and microvessel-density levels in initial biopsy for prostate cancer

    by Enis Kervancioglu, Murat Kosan, Hilal Erinanc, Umut Gonulalan, Ahmet Ibrahim Oguzulgen, Esra Zeynep Coskun, Hakan Ozkardes

    Angiogenesis is an important factor in the development and progression of prostate cancer (PCA). We aimed to investigate the values of vascular-endothelial-growth-factor (VEGF) expression level and microvessel density (MVD) in the prediction of PCA diagnosis at repeated prostate biopsy (re-PBx). We retrospectively evaluated 167 patients with re-PBx according to elevated prostate-specific antigen levels, suspicious digital rectal examination, and the presence of premalignant lesions. Patients with PCA on re-PBx were included in the cancer group (n = 17). Patients with benign prostatic hyperplasia or normal tissues on re-PBx were included in the control group (n = 21). The groups were compared according to the expression level of VEGF and MVD in initial prostate biopsy. There was no statistically significant difference between groups according to age and serum prostate-specific-antigen values. The mean VEGF scores of the cancer and control groups were 232.64 ± 11.14 and 183.09 ± 14.56, respectively (p < 0.05). The mean MVD of the biopsy samples in the cancer and control groups were 246.47 ± 17.59 n/mm(2) and 197.33 ± 16.26 n/mm(2), respectively (p < 0.05). The cutoff values of VEGF scores and MVD were set as 200 and 215, respectively, for PCA detection in our study. Our results showed that the expression level of VEGF and MVD significantly increased in the initial prostate-biopsy samples of patients with PCA diagnosed with re-PBx. The evaluation of VEGF expression level and MVD might have an important value in the prediction of PCA at re-PBx. The expression level of VEGF and MVD should be kept in mind as PCA-related histopathological changes that indicate the increased angiogenesis in prostatic tissue.


    • 1 January 2015
      • Vol. 65  (1) , 90-2

    Urethral duplication: a rare cause of recurrent urinary infection.

    by Tufan Cicek, Yalcin Kizilkan, Gökcen Coban, Murat Kosan

    Urethral duplication is quite a rare congenital anomaly with ill-defined aetiology. Patients often present with penile deformity; recurrent urinary infections, urinary incontinence, serosal discharge from the accessory urethra, and difficulty in urinating. Urethral duplication is most commonly grouped according to the Efmann classification. It has 3 main types as Type I, II, and III. There is no consensus on its therapy. There are non-surgical solutions, including follow-up without therapy, as well as many surgical options, including urethral reconstruction. Anatomical urethra and the external sphincter should absolutely be delineated when a surgery is contemplated. We herein report the case of a two-year-old male patient referred to our clinic with recurrent urinary infection, bilateral hydronephrosis and difficulty in urinating who was diagnosed with urethral duplication. We discuss our findings with review of the relevant literature.


  • Open Access

    Laparoskopik Transperitoneal Basit Nefrektomi: Tek Merkez Deneyimi

    by Tufan Çiçek, Erhan Şen, Murat Gönen, Umut Gönülalan, Murat Koşan, Bülent Öztürk

    Amaç: Bu çalışmada kliniğimizde uyguladığımız transperitoneal laparoskopik basit nefrektomi ameliyatının başarısını ve oluşan komplikasyonları değerlendirmeyi amaçladık. Materyal-Metod: Şubat 2005 ve Kasım 2013 yılları arasında Başkent Üniversitesi Konya Uygulama ve Araştırma Merkezi Üroloji kliniğinde transperitoneal laparoskopik basit nefrektomi ameliyatı yapılan hastaların dosyaları retrospektif olarak incelendi. Hastaların demografik özellikleri, ameliyat süreleri, ameliyat öncesi ve sonrası laboratuvar sonuçları, hastanede kalış ve takip süreleri, cerrahi işlem esnasında ve sonrasında oluşan komplikasyonlar kayıt edildi. Bulgular: Çalışmada toplam 58 hasta vardı. Bu hastaların 27"si erkek 31"i bayandı. Yaş ortalaması 45.3 ± 17.12 (6-79) yıl olarak bulundu. Ameliyat süresi ortalama 104.4 ± 36.5 (40-185) dakika idi. Hastaların ortalama hastanede kalış süresi 2.7 ± 0.7 (2-5) gün idi. Hastaların ameliyat öncesi ve sonrası hemoglobin değeri sırası ile 13.7 ± 1.74, 12.4 ± 1.73 mg/dl olarak bulundu. Ameliyat sonrası hemoglobin düzeyi ameliyat öncesine istatiksel olarak anlamlı düşük bulundu (p

  • Reply by the authors.

    by Umut Gonulalan, Tufan Cicek, Murat Kosan

  • Skin-to-Stone Distance Has No Impact on Outcomes of Percutaneous Nephrolithotomy

    by Umut Gonulalan, Murat Akand, Gokcen Coban, Tufan Cicek, Murat Kosan, Serdar Goktas, Hakan Ozkardes

    Objective: Skin-to-stone distance (SSD) is a stronger factor than body mass index in predicting the success of shock wave lithotripsy. We aimed to evaluate the impact of SSD on outcomes of percutaneous nephrolithotomy (PCNL). Materials and Methods: The medical records of 1,280 patients who had undergone PCNL between April 2007 and February 2012 were evaluated retrospectively. 192 patients who had had preoperative non-contrasted computed tomography and single renal access were included the study. According to this median SSD value, patients were divided into two groups: group 1 (SSD ≤94 mm) (n = 92) and group 2 (SSD >94 mm) (n = 90). The groups were compared according to operative and postoperative parameters. Results: We found no significant differences between the two groups with regard to stone-free rate, operation time, fluoroscopy time, hospitalization time, visual analog score of pain, stone burden, transfusion rates and complication rates. On the other hand, the mean body mass index of group 1 was significantly lower than that of group 2 (p < 0.05). Conclusions: In this retrospective review of patients undergoing PCNL, we found that SSD has no impact on operative and postoperative outcomes. These results were in accordance with the safety of PCNL in obese patients.


  • An unusual complication of a double-J ureteral stent: Renal parenchymal perforation in a solitary kidney

    by Umut Gönülalan, Murat Akand, Eray Hasırcı, Murat Koşan

    Double-J ureteral stenting is commonly used in urological practice and has various complications. We report a patient with a renal parenchymal perforation and perirenal hematoma due to a double-J ureteral stent in a solitary kidney. This complication of ureteral stents is rarely observed and is life-threatening.


  • Spinal Anesthesia Is an Efficient and Safe Anesthetic Method for Percutaneous Nephrolithotomy

    by Tufan Cicek, Umut Gonulalan, Rafi Dogan, Murat Kosan, Okan Istanbulluoglu, Murat Gonen, Bülent Ozturk, Hakan Ozkardes


  • Acetylsalicylic acid protects erectile function in diabetic rats

    by G. Hafez, U. Gonulalan, M. Kosan, E. Arioglu, B. Ozturk, M. Cetinkaya, S. Gur

    We aimed to evaluate the effect of acetylsalicylic acid (ASA) treatment on diabetes-induced erectile dysfunction. Adult male Sprague-Dawley rats were divided into four groups as follows: (i) control (C), (ii) diabetic (D), (iii) ASA-treated control (C+ASA) and (iv) ASA-treated diabetic (D+ASA) groups. In groups 2 and 4, diabetes was induced by injection of 35 mg kg(-1) streptozotocin. ASA (100 mg kg(-1) day(-1) , orally) was administrated to rats in groups 3 and 4 for 8 weeks. Both intracavernosal pressure (ICP) and mean arterial blood pressure (MAP) were measured in in vivo studies. In organ bath, the relaxation responses to acetylcholine (ACh), electrical field stimulation (EFS) and sodium nitroprusside were tested in corpus cavernosum (CC) strips. The mRNA expression for neuronal nitric oxide synthase (nNOS) was calculated using reverse transcription polymerase chain reaction technique. In in vivo experiments, diabetic rats displayed reduced ICP/MAP values, which were normalised with ASA treatment. The relaxant response to high-dose ACh and EFS at low frequencies (1-8 Hz) in CC strips from the D+ASA group were significantly higher when compared to the D group. Treatment with ASA normalised the raised mRNA expressions of nNOS in diabetic penile tissues. ASA may be involved in mRNA of protein synthesis of NO released from nonadrenergic and noncholinergic cavernosal nerve in diabetes.


  • A New Hemostatic Agent (Ankaferd Blood Stopper ® ) in Tubeless Percutaneous Nephrolithotomy: A Prospective Randomized Study

    by Mustafa Okan Istanbulluoğlu, Mehmet Kaynar, Tufan Çiçek, Murat Koşan, Bülent Öztürk, Hakan Özkardeş

    The present study evaluates the efficiency and reliability of a hemostatic agent ABS (Ankaferd Blood Stopper(®)) in tubeless percutaneous nephrolithotomy (PCNL). A total of 90 patients were divided into two subgroups. The first group had ABS applied during the intervention, whereas the control group underwent regular tubeless PCNL in this prospective randomized study. Age, stone size, operative time, postoperative hemoglobin change, renal parenchyma thickness, postoperative ureteral catheter removal time, access number, nephroscope time, blood transfusion rate, serum creatinine change, complication rate, visual analogue scale (VAS), and hospitalization time were compared between the two groups. Preoperative and postoperative data obtained from both groups were compared. No statistically meaningful differences were found related to variables of mean age, stone size, access number, serum creatinine change, operative time, renal parenchyma thickness, VAS scores, and hospitalization period. Whereas the nephroscope time (minutes) was longer in the ABS group (Group 1 [G1]:3, 33±1, 72 vs G2:2, 62±1, 43, P=0.035), hemoglobin (Hb) decrease, and urine clarity time were statistically lower compared with the control group. Hb decrease was (mg/dL) (G1: 1.40±1.04 vs G2: 1.84±1.15, P=0.034), and urine clarity time was (hour) (G1: 9.60±5.50 vs G2: 11.95±4.71, P=0.012), respectively. Complications were encountered in three (6.6%) patients of the ABS group and in four (8.8%) of the control group. ABS is an efficient and reliable hemostatic agent in tubeless PCNL. Comparative studies are needed, however, with other hemostatic agents that might be applied in tubeless PCNL.